Granules India Limited

BSE:532482 Stock Report

Market Cap: ₹144.7b

Granules India Past Earnings Performance

Past criteria checks 5/6

Granules India has been growing earnings at an average annual rate of 4%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 13% per year. Granules India's return on equity is 14.2%, and it has net margins of 10.9%.

Key information

4.0%

Earnings growth rate

5.0%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate13.0%
Return on equity14.2%
Net Margin10.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Granules India makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532482 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2444,7784,8726,6060
30 Jun 2447,0074,9216,5000
31 Mar 2445,0644,0536,2670
31 Dec 2345,2613,9535,8770
30 Sep 2345,1663,9395,4990
30 Jun 2344,7794,3695,1870
31 Mar 2345,1195,1664,8720
31 Dec 2243,4645,0804,7810
30 Sep 2241,9704,8454,6430
30 Jun 2239,3464,2014,3910
31 Mar 2237,6494,1284,1230
31 Dec 2135,3434,2934,1130
30 Sep 2133,8204,7534,0690
30 Jun 2133,5185,5824,1890
31 Mar 2132,3755,4954,2480
31 Dec 2030,3815,1423,4120
30 Sep 2028,9764,3143,2280
30 Jun 2027,3903,6362,8570
31 Mar 2025,9863,3543,2170
31 Dec 1926,1213,0712,5370
30 Sep 1925,3993,0342,4250
30 Jun 1924,2122,6792,1660
31 Mar 1922,7922,3642,2690
31 Dec 1821,6971,9282,1580
30 Sep 1819,4871,6752,0370
30 Jun 1817,6031,4761,7640
31 Mar 1816,8461,3261,8010
31 Dec 1715,3611,5781,6920
30 Sep 1714,7851,6191,6380
30 Jun 1714,4561,6241,4530
31 Mar 1714,1061,6451,5040
31 Dec 1614,9711,4731,61485
30 Sep 1614,6261,3741,47963
30 Jun 1614,5241,2891,42328
31 Mar 1613,5721,2301,2830
31 Dec 1514,1471,0772,377187
30 Sep 1513,8951,0412,366160
30 Jun 1513,3079522,317134
31 Mar 1512,9379091,1550
31 Dec 1412,5739212,26151
30 Sep 1412,2179042,18857
30 Jun 1411,7868341,47264
31 Mar 1410,9737522,05194
31 Dec 139,8376401,65649

Quality Earnings: 532482 has high quality earnings.

Growing Profit Margin: 532482's current net profit margins (10.9%) are higher than last year (8.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532482's earnings have grown by 4% per year over the past 5 years.

Accelerating Growth: 532482's earnings growth over the past year (23.7%) exceeds its 5-year average (4% per year).

Earnings vs Industry: 532482 earnings growth over the past year (23.7%) exceeded the Pharmaceuticals industry 20%.

Return on Equity

High ROE: 532482's Return on Equity (14.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 14:06
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Granules India Limited is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harith AhamedAvendus Spark
Cyndrella CarvalhoCentrum Broking Limited
Rashmi Sancheti ShettyCGS International